Milind A. Phadnis, MS, PhD

Professional Background

Milind Phadnis is an Associate Professor in Department of Biostatistics & Data Science at the University of Kansas Medical Center. His methodological interests are in the field of Survival Analysis and Design of Clinical Trials. He has collaborated extensively with researchers from nephrology, stroke, neurology, oncology and many other areas. He is the co-director of the Biostatistics section of Investigator Initiated Trials supported by the Cancer Center at his university. He has also served as the site-PI for an American Heart Association grant and is a two-time winner of Biostatistics & Epidemiology Research Design award at his university. He teaches Masters and PhD level courses in Biostatistics to students in his department and also Service-level courses to students from other departments. He also won the Outstanding Graduate Teaching Award for the 2020-21 academic year.

• PhD, Biostatistics, University of Alabama-Birmingham, Birminbham, AL
• MS, Industrial Engineering, University of Alabama, Tuscaloosa, AL
• Other, Production Engineering, Fr. Conceicao Rodrigues College of Engineering, Mumbai, Maharashtra

• Association for Clinical and Translational Statisticians, Member, 2017 - Present
• Investigator Initiated Trials, Member, 2016 - Present
• University of Kansas Cancer Center, Member, 2015 - Present
• American Statistical Association, Member, 2010 - Present

---

• Wetmore JamesB, Phadnis MilindA, Mahnken JonathanD, Ellerbeck EdwardF, Rigler SallyK, Zhou Xinhua, Shireman TheresaI. 2014. Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients.. Clinical Journal of the American Society of Nephrology, 9 (4), 756-763. https://cjasn.asnjournals.org/content/clinjasn/9/4/756.full.pdf
• Phadnis MilindA, Wetmore JamesB, Mayo MatthewS. 2017. A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution.. Statistics in Medicine, 36, 4121-4140. https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.7421
• Phadnis MilindA, Wetmore JamesB, Shireman TheresaI, Ellerbeck EdwardF, Mahnken JonathanD. 2017. An ensemble survival model for estimating relative residual longevity following stroke: Application to mortality data in the chronic dialysis population.. Statistical Methods in Medical Research, 26 (6), 2667-2680. https://journals.sagepub.com/doi/pdf/10.1177/0962280215605107
• Phadnis MilindA, Mayo MatthewS. 2021. Sample size calculation for two-arm trials with time-to-event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions.. Biometrical journal, 63 (7), 1406-1433. https://doi.org/10.1002/bimj.202000043
• Sharma Priyanka, Abramson VandanaG, O'Dea Anne, Nye Lauren, Mayer Ingrid, Pathak HarshB, Hoffmann Marc, Stecklein ShaneR, Elia Manana, Lewis Sharon, Scott Jecinta, De Jong JilliannA, Wang YenY, Yoder Rachel, Schwensen Kelsey, Finke Karissa, Heldstab Jaimie, LaFaver Stephanie, Williamson StephenK, Phadnis MilindA, Reed GregoryA, Kimler BruceF, Khan QamarJ, Godwin AndrewK. 2021. Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.. Clinical Cancer Research, 27 (14), 3896-3904. https://doi.org/10.1158/1078-0432.ccr-20-4879
• Waleed Muhammad, He Jianghua, Phadnis MilindA. 2021. Some design considerations incorporating early futility for single-arm clinical trials with time-to-event primary endpoints using Weibull distribution.. Pharmaceutical Statistics, 20 (3), 610-644. https://dx.doi.org/10.1002/pst.2097
• Jain Nishank, Phadnis MilindA, Hunt SuzanneL, Dai Junqiang, Shireman TheresaI, Davis ClaytonL, Mehta JawaharL, Rasu RafiaS, Hedayati SSusan. 2021. Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis.. Kidney International Reports, 6 (9), 2381-2391. https://doi.org/10.1016/j.ekir.2021.06.031
• Saeed Anwaar, Park Robin, Dai Junqiang, Al-Rajabi Raed, Kasi Anup, Baranda Joaquina, Williamson Stephen, Saeed Azhar, Ripp Jacob, Collins Zachary, Mulvaney Kelly, Shugrue Molly, Firth-Braun Jeanette, Godwin AndrewK, Madan Rashna, Phadnis Milind, Sun Weijing. 2023. Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. Cell Reports Medicine, 4 (2), 1-11. https://doi.org/10.1016/j.xcrm.2023.100916
• Sun Weijing, Veeramachaneni Nirmal, Al-Rajabi Raed, Madan Rashna, Kasi Anup, Al-Kasspooles Mazin, Baranda Joaquina, Saeed Anwaar, Phadnis MilindA, Godwin AndrewK, Olyaee Mojtaba, Streeter Natalie, Nagji Alykhan, Dai Junqiang, Williamson Stephen . 2023. A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma. Cancer Medicine, 12 (15), 16098-16107. https://pubmed.ncbi.nlm.nih.gov/37326317/
• Waleed Muhammed, He Jianghua, Phadnis MilindA. 2023. Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter. Journal of Biopharmaceutical Statistics, 34 (4), 469-487. https://doi.org/10.1080/10543406.2023.2234998